CD31
-CD140b + SMA ; and during tissue expansion or repair, APCs could also differentiate into tissue-specific cell types (e.g., muscle and fat) Thus, in vitro, APCs fulfill all criteria for being VSCs. Meanwhile, in vivo evidence is still limited and will require further investigation. 
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ISI: Ketertarikan para ilmuwan akan Vascular Stem Cells
(VSCs) baru akhir-akhir ini, sehingga pemahaman mengenai VSCs dan fungsinya masih sangat kurang. Penelitian Mesenchymal Stem Cells (MSCs) selama beberapa dekade terakhir, yang diduga adalah VSCs, belum mendapatkan titik temu. Penelitian yang intensif selama beberapa dekade mengenai pericyte juga tidak dapat memecahkan masalah ini. Artikel ini menggambarkan bahwa Adventitial Progenitor Cells (APCs) merupakan kandidat kuat sebagai VSCs dibanding pericyte, dengan tidak mengesampingkan pendapat yang menyatakan bahwa VSCs adalah pericyte. Introduction ideal site to place stem cells strategically in pools that can be expanded rapidly to respond to injury and disease. This hypothesis suggests an interesting interface, where stem cell biology could greatly contribute to our understanding in the role of stem cells in vascular disease. (7) Blood vessels are composed of ECs that provide the inner (luminal) surface of the vessel in contact with blood, and mural cells that interact with the outer (abluminal) surface of ECs. Mural cells most often are pericytes, and the vessel wall of the vast majority of vessels in body, which comprise microcirculation, consists simply of ECs surrounded by pericytes. Larger vessels, especially arterioles, arteries and veins, are invested with SMCs and elastic fibers that provide contractility, and larger arteries and veins also have an organized structure of fibroblasts that produce collagen.(3) The diverse embryonic sources of both ECs and mural cells argue against a single type of VSCs, analogous to the hematopoietic stem cell, which would both self-renew and contribute to all vascular lineages. It can also be argued that there is no need for a VSC, as once ECs differentiate they retain the capacity to proliferate and form new vessels via sprouting angiogenesis, and mesenchymal cells capable of recruitment to mural lineages reside in most local environments. However, both vascular compartmentsendothelial and mural are associated with stem cells, progenitor cells or both during development. (8) (9) (10) Vascular structures are unique. They are expected to take up little space and at the same time perfuse and deliver nutrients to all locations in the body. Thus, they will have to show inventiveness in penetrating organs and adapting to the spatial structure of each organ. Considering the stringent space restrictions, it is an interesting problem how stem cells are provided locally for repair or for the development of new vessels. Strategies will be needed to keep the number of progenitor cells low, yet keep them available for rapid mobilization and expansion. (11, 12) Stem cell pools may be one way that the vasculature responds to these requirements. Stem cells are often found near basement membrane, which has suggested the existence of so-called ''niches'' or specialized microenvironments for stem cells. (13, 14) A cell population in proximity to the basement membrane would be perfectly located to supply both ECs and smooth muscle cells (SMCs) progenitor cells, enabling quick regeneration. The origin of such progenitor cells would include resident vascular as well as circulating stem cells. Resident stem cells may be reserved and positioned during development (15) , whereas circulating stem cells, mainly derived from the bone marrow (BM) (16, 17) , may be rapidly mobilized from the circulation and modified by the vascular context. There is dramatic evidence of multipotent cells in the vasculature, especially in vascular calcification and ectopic bone formation. (18, 19) Multiple studies have demonstrated that vascular mesenchymal cells, including microvascular pericytes, so-called calcifying vascular cells and SMCs, undergo osteochondrogenic lineage differentiation spontaneously or under special conditions such as hyperphosphatemia. (18, 20) In recent times, these traditional views of vascular biology have been revised by the discovery of immature stem/progenitor cell populations, relevant to endothelial (21, 22) , smooth muscle (23) (24) (25) , myeloid (26) and multipotent mesenchymal lineage (27) that have been shown to participate in postnatal vasculogenesis and vascular wall remodeling. An increasing body of evidence points to the existence of these different progenitor cell types within embryonic, fetal and adult vessel walls, where they may reside either constitutively or appear as a result of circulating migration.(2) Thus, the stem cell biologist could greatly support vascular biology with knowledge of how to reverse terminal differentiation toward more stem cell-like characteristics, and the relation between stages of differentiation and the patterning of tissues, all central in vascular regeneration and disease.
RINGKASAN:
Angiogenesis and "Vasculogenic Zone"
Development of vasculature and its subsequent homeostasis are integral components of embryogenesis, fetal organogenesis, maintenance of health and normal function of adult tissues. In embryonic life, emergence of ancestral stem/progenitor cells for both ECs and hematopoietic cells gives rise to the formation of blood vessels, which are then stabilized by incorporation of peri-ECs and stromal elements. (28) New blood vessel formation (neovascularization) also continues in adults and is a key contributor to both physiological and pathological processes, including tissue ischemia, repair and regeneration, atherosclerosis, tumor growth and metastasis. (1) Postnatal vascular wall comprises three concentric layers consisting of a limited number of cell types. Tunica intima has an EC lining which interfaces with blood, media contains several layers of SMCs, and adventitia is made up of stromal and adipose tissue, along with the vasa and nerva vasorum. Disruption of vessel wall integrity is associated with pathogenesis of various disease processes, including atherosclerosis, aneurysm formation, vasculitis, allograft vasculopathy and post-intervention restenosis, which in turn may occlude tissue blood supply, leading to ischemia or infarction.(2) Up until the last decade, it was widely believed that cellular elements of adult vessel wall are terminally differentiated and thus relatively quiescent. Angiogenesis, defined as the formation of new blood vessels from preexisting ECs, was considered to be the only mechanism by which neovascularization occurred after birth. (1) Main steps of this process comprise ECs migration, proliferation and tube formation. Accumulating data indicate a role for circulating endothelial precursor cells and/ or BM-derived endothelial precursor cells involved in the new blood vessel formation (21, (29) (30) (31) (32) , a process defined as postnatal vasculogenesis. More recent data suggest a role for tissue-bound precursor cells as source of vascular cells and concomitantly accumulating macrophages during collateral vessel growth. (33) The existence of local tissue-bound adult precursor cells has been reported for different organs (34, 35) , but not yet for the wall of adult blood vessels (36) . Our data suggest the existence of a 'vasculogenic zone' in the adult human vascular wall that is, to our knowledge, the first reported location for endothelial progenitor cells (EPCs) outside the BM, which may serve as a source for progenitor cells for postnatal vasculogenesis, contributing to tumor vascularization and local immune response. (26) The local activation and migration of vascular wall resident progenitor cells (VW-PCs) is believed to contribute to cell turnover during physiologic and pathogenic vascular remodeling and neovascularization, while there may also be dynamic, bidirectional exchange of progenitor cells between the vessel wall and peripheral circulation throughout adult life. More recently, hypoxia-independent pathways have also been described, mediated primarily by inflammation and activation of the toll-like receptor. (54) On the basis of the aforementioned observations, it is reasonable to develop the following hypothesis: Adventitial -derived vasa vasorum neovascularization develops under the trigger of oxidized low-density lipoprotein deposits in the intima, mediated by hypoxia and toll-like receptors. Such neovessels may contribute to the removal of intimal fat when the concentration of low-density lipoprotein is lower in the neovessel circulation than in the intima (lowdensity lipoprotein concentration gradient). However, extravasation of red blood cells (RBCs) from leaky neovessels attracts macrophages to the field, both at the intima-media junction and the shoulders of the plaque. Macrophage erythrophagocitosis leads to cell activation at these crucial sites of the plaque. Then macrophage-derived matrix metalloproteinase secretion leads to rupture of the internal elastic lamina(55) and fibrous cap collagenolysis, precipitating plaque rupture and thrombosis (56) .
Diabetes mellitus, through the impairment of vascular stem and progenitor cells entails a defective repair of the injured endothelium.(58) To stop the progression of these complications and to repair the damage, we would need to either replace the damaged ECs or create brand new vascular networks. Considering mounting evidence of stem/ progenitor cells in various tissues including the blood vessel wall(50), we can speculate that the reason diabetic patients exhibit impaired repair mechanisms is because these stem/ progenitor cells are also affected (60) . Ideally, it would be one cell type or a subpopulation that can produce both ECs and the supportive perivascular cells. The notion of a specific VSC able to produce mature/functional cells of the blood vessels is slowly gaining momentum.
The exact identity of the VSCs is still not clear. There is ample evidence that these VSCs are found in the BM and 
What are Vascular Stem Cells?
MSCs exist in most adult tissues and have been located near or within blood vessels. Although ''perivascular'' has been commonly used to describe such locations, increasing evidence points at the vessel wall as the exact location. Thus, VSCs is recommended as a more accurate term for MSCs. Furthermore, 2 cell populations, namely pericytes and Advential Progenitor Cells (APCs), are the likely VSCs. The pericyte evidence relies on the so-called pericytespecific markers, but none of these markers is pericyte specific. In addition, pericytes appear to be too functionally diverse and sophisticated to have a large differentiation capacity. On the other hand, APCs are more naıve functionally and, therefore, more akin to being VSCs. These cells spontaneously in vitro-differentiate into pericytes, and can be induced to differentiate into vascular cells (ECs and SMCs) and mesenchymal cells (e.g., bone, cartilage, and fat). (6) While EPCs are defined as originating from BM and circulating in the blood, ''true'' VSCs (as defined earlier, in introduction) are expected to reside within the blood vessel wall. At this location, 3 distinct cell types exist: ECs and pericytes in capillaries, and additionally, SMCs in larger vessels. In addition, a mixed population of cells (macrophages, dendritic cells, fibroblasts, and progenitor cells) resides in the adventitia. (66, 67) The possibilities for these vessel wall cells to be stem or progenitor cells have been reviewed, for example, in these recent articles. (2, 3, 7, 15, (66) (67) (68) (69) (70) (71) (72) In particular, pericytes and APCs have emerged as the most plausible VSCs.
Pericytes, the mural cells of blood microvessels, have recently come into focus as regulators of vascular morphogenesis and function during development, cardiovascular homeostasis and disease. Pericytes are implicated in the development of diabetic retinopathy and tissue fibrosis, and they are potential stromal targets for cancer therapy. Some pericytes are probably MSCs or progenitor cells, which give rise to adipocytes, cartilage, bone and muscle. However, there is still confusion about the identity, ontogeny, and progeny of pericytes. (73) Pericytes and ECs are intimately connected by tight and gap junctions, and each pericyte may be in contact with several ECs via elongated processes wrapping around and along the blood vessel. (74, 75) In larger vessels, pericytes may be observed not only as sub-ECs in the inner intimal layer, but also in the media and adventitia associated with the vasa vasorum. (76) Evidence is accumulating to suggest a close relationship between MSCs and pericytes. Conceivably, given that MSCs (and pericytes) isolated from disparate tissues exhibit subtle variability in differentiation capability, it is possible that MSCs are ubiquitous perivascular progenitor cells distributed throughout the body, but with a degree of lineage allegiance to their host tissue.(68) Conventional views of the tunica adventitia as a poorly organized layer of vessel wall composed of fibroblasts, connective tissue, and perivascular nerves are undergoing revision. Recent studies suggest that the adventitia has properties of a stem/progenitor cell niche in the artery wall that may be poised to respond to arterial injury. It is also a major site of immune surveillance and inflammatory cell trafficking and harbors a dynamic microvasculature, the vasa vasorum, that maintains the medial layer and provides an important gateway for macrophage and leukocyte migration into the intima. In addition, the adventitia is in contact with tissue that surrounds the vessel and may actively participate in exchange of signals and cells between the vessel wall and the tissue in which it resides. (30) Unlike the media and intima, which are synonymic with smooth muscle and endothelium, respectively, the adventitia does not have a defined synonymic cell type. However, when an artery's cross-section is stained for CD34, 2 concentric rings of cells corresponding to the intima and adventitia are revealed. The inner ring is thin, compact, and complete, and is undoubtedly the endothelium that also stains positive for CD31. The outer ring, which is outside of the media and thus belongs to the adventitia, is irregular, loose, incomplete, and distinctively CD31
-. This population of CD34 + CD31 -adventitial cells is now increasingly believed to be VSCs. (26, 77, 78) Therefore, the adventitia consists of a complex community of interacting cell types, and abundant evidence now indicates that a better understanding of molecular mechanisms for homeostasis, repair, and disease of the vessel wall will require a greater appreciation of the integrated role of the adventitia with the intimal and medial layers. This population of CD34 + CD31 -adventitial cells was also said to exist in all of the human organs studied, including urinary bladder, testis, prostate, kidney, lung, heart, liver, and brain, the term ''vasculogenic zone'' to denote the CD34 +
CD31
-ring in the adventitia of human blood vessels, and suggested that the CD34 + CD31 -cells might be progenitor cells for postnatal vasculogenesis. MSC-like cells residing in the same vasculogenic zone were shown to be CD44 + but CD34 vascular progenitor cells in the adventitia could differentiate into SMCs which contribute to atherosclerosis. (6) The Sca1 expression mentioned earlier in the adventitia has been independently confirmed in mouse aorta and mesenteric and femoral arteries. (25) More importantly, Sca1 + cells immune-selected from the aortic adventitia were found capable of smooth muscle and endothelial differentiation. Moreover, when the Sca1-selected cells were treated with Bone Morphogenetic Protein 2 (BMP2), colonies formed that stained positive by alizarin red, suggesting osteogenic differentiation. These findings thus reinforced the existence of APCs.(6) Indeed, pericytes' functions are more than blood flow regulation, but as diverse as performing vessel stabilization, vascular tone regulation, vessel permeability regulation, local tissue homeostasis maintenance, macrophage-like properties, immunologic defense, coagulation intervention, and control of the quiescent and angiogenic stages of blood vessels. (81) Thus, with these large degrees of functional diversity and sophistication, how can pericytes still maintain a large capacity for differentiation, including the ability to become many different cell types with each having its own sophisticated functions. On the other hand, APCs are not known to have any specific physiological function and are, thus, developmentally more akin to primitive cells whose primary role is serving as progenitors for various specialized cell types. In the capillary, which lacks a defined adventitia, the APC equivalent still exists, as evidenced by the presence of the same CD34 + CD31 -CD140b -SMA -cells in both the adventitia and the capillary. (78, 82) Thus, it has been postulated that, within the vasculature, APCs could differentiate into pericytes (CD34 -CD31 + CD31 -cells located in the ''vasculogenic zone'' of the thoracic artery, between the tunica media and tunica adventitia, can also give rise to endothelium; hence, they could represent a resident pool of EPCs for postnatal vasculogenesis. (26) The vessel wall has a substantial intrinsic capacity for wound repair. Under normal conditions, the artery wall in adult animals has very low to undetectable rates of ECs or SMC proliferation. When subjected to overstretch injury, however, proliferation rates in all layers of artery wall can increase more than 100-fold. (47, 93) Because of its location between the vessel wall and the surrounding tissues in which the vessel is located, adventitial cells could, in principle, participate in tissue repair or disease processes in either the vessel wall itself or in surrounding nonvascular tissues. (67) An early event observed following many forms of arterial injury is adventitial inflammation and an accumulation of monocytes and activated macrophages in the adventitia. (94) (95) (96) This local inflammatory response may be necessary for down-regulation of the ongoing adventitial niche signaling that maintains Sca1 + cells as progenitors, thus resulting in the "release" of these progenitor cells to adopt other cell fates.
Direct evidence for the capability of adventitial cells to migrate through the media and into the intima has been obtained by transplanting cells onto the adventitial side of an artery and monitoring movement of these cells following arterial injury. (24, 90, 97, 98) In addition, an intriguing possibility is that adventitial Sca1+ progenitor cells may be stimulated by arterial injury to adopt an SMC-like phenotype and migrate into the media and possibly into the intima, and thereby participate in neointimal formation. (24, 25) Development of new cell therapeutics based on detailed understanding of generation of VSCs holds great promise.
Whereas uncertainties concerning cell lineages and identities remain, there is sufficient available information to consider a scenario in which VSCs play critical physiological roles in vascular development and homeostasis, as sources of fibrogenic cells in pathological situations, and as a possible
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Conclusion
VSCs is defined as ''cells that reside within the blood vessel wall and can differentiate into all of the cell types that constitute a functional blood vessel.'' Specifically, the cell types that VSCs can differentiate into include ECs and pericytes in the capillary, and additionally, smooth muscle and adventitial cells in larger vessels. They can probably also differentiate into specific mesenchymal cells of their native tissue, or they can induce the replication/differentiation of such cells via growth factor secretion. Consistent with these proposed VSC characteristics, APCs are the most likely candidates for being VSCs.
These findings provide unprecedented insight into the role of stem cells in vascular diseases and remodeling, which suggests that vascular diseases are stem cell diseases. These findings may have transformative impact on vascular biology and diseases, and may lead to new therapies by using VSCs as a therapeutic target. reservoir of stem or progenitor cells for adult vascular repair. In the future, defining the mechanisms regulating vascular development would be the fundamental for treating vascular diseases.
